HRT FINANCIAL LP - CHINA SXT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P116. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$86,000
-23.2%
83,890
+7.7%
0.00%0.0%
Q2 2021$112,000
-36.4%
77,901
-18.4%
0.00%
-50.0%
Q1 2021$176,000–95,500–0.00%–
 Download
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
HRT FINANCIAL LP 95,500$176,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,642$49,0000.00%
GOLDMAN SACHS GROUP INC 26,408$49,0000.00%
Citadel Advisors 53,418$99,0000.00%
ROYAL BANK OF CANADA 625$1,0000.00%
UBS Group AG 8,523$16,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders